Related references
Note: Only part of the references are listed.A new role for sphingosine: Up-regulation of Fam20C, the genuine casein kinase that phosphorylates secreted proteins
Giorgio Cozza et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Chimeric peptides as modulators of CK2-dependent signaling: Mechanism of action and off-target effects
Sofia Zanin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells
Cinzia Franchin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Proteomics perturbations promoted by the protein kinase CK2 inhibitor quinalizarin
Cinzia Franchin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
A Single Kinase Generates the Majority of the Secreted Phosphoproteome
Vincent S. Tagliabracci et al.
CELL (2015)
MEK Inhibitor PD-0325901 Overcomes Resistance to CK2 Inhibitor CX-4945 and Exhibits Anti-Tumor Activity in Head and Neck Cancer
Yansong Bian et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2015)
The Selectivity of CK2 Inhibitor Quinalizarin: A Reevaluation
Giorgio Cozza et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Quinone Reductase 2 Is an Adventitious Target of Protein Kinase CK2 Inhibitors TBBz (TBI) and DMAT
Kevin K. K. Leung et al.
BIOCHEMISTRY (2015)
Antitumoral activity of allosteric inhibitors of Protein kinase CK2
Virginie Moucadel et al.
Oncotarget (2015)
Synthesis, Biological Evaluation and Molecular Modeling of Substituted Indeno[1,2-b]indoles as Inhibitors of Human Protein Kinase CK2
Faten Alchab et al.
PHARMACEUTICALS (2015)
Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy
Betsy T. Kren et al.
BREAST CANCER RESEARCH (2015)
Efficient Modification of Alpha-Synuclein Serine 129 by Protein Kinase CK1 Requires Phosphorylation of Tyrosine 125 as a Priming Event
Jonas Kosten et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Pharmacological Assessment Defines Leishmania donovani Casein Kinase 1 as a Drug Target and Reveals Important Functions in Parasite Viability and Intracellular Infection
Najma Rachidi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Casein kinase: the triple meaning of a misnomer
Andrea Venerando et al.
BIOCHEMICAL JOURNAL (2014)
Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis
Manuel Valiente et al.
CELL (2014)
Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: structural features and pharmacological potential
Giorgio Cozza et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
A complex signaling network involving protein kinase CK2 is required for hepatitis C virus core protein-mediated modulation of the iron-regulatory hepcidin gene expression
Pelagia Foka et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
In vivo treatment with the casein kinase 2 inhibitor 4,5,6,7-tetrabromotriazole augments the slow afterhyperpolarizing potential and prevents acute epileptiform activity
Hannes Brehme et al.
EPILEPSIA (2014)
Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia
Marcus Jaeras et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Difluoro-dioxolo-benzoimidazol-benzamides As Potent Inhibitors of CK1δ and ε with Nanomolar Inhibitory Activity on Cancer Cell Proliferation
Julia Richter et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Protein Kinase CK-1 Inhibitors As New Potential Drugs for Amyotrophic Lateral Sclerosis
Irene G. Salado et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Attenuation of β-Amyloid-Induced Tauopathy Via Activation of CK2α/SIRT1: Targeting for Cilostazol
Hye Rin Lee et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
Phosphoprotein Secretome of Tumor Cells as a Source of Candidates for Breast Cancer Biomarkers in Plasma*
Anna M. Zawadzka et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Mechanism and Efficacy of Sub-50-nm Tenfibgen Nanocapsules for Cancer Cell-Directed Delivery of Anti-CK2 RNAi to Primary and Metastatic Squamous Cell Carcinoma
Gretchen M. Unger et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia
L. R. Martins et al.
LEUKEMIA (2014)
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling
F. Buontempo et al.
LEUKEMIA (2014)
CDK/CK1 inhibitors roscovitine and CR8 downregulate amplified MYCN in neuroblastoma cells
C. Delehouze et al.
ONCOGENE (2014)
Microtubules Depolymerization Caused by the CK1 Inhibitor IC261 May Be Not Mediated by CK1 Blockage
Martin Stoeter et al.
PLOS ONE (2014)
Tenfibgen Ligand Nanoencapsulation Delivers Bi-Functional Anti-CK2 RNAi Oligomer to Key Sites for Prostate Cancer Targeting Using Human Xenograft Tumors in Mice
Janeen H. Trembley et al.
PLOS ONE (2014)
Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis
Vincent S. Tagliabracci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specific cell-permeable peptide inhibitor
Leila R. Martins et al.
ONCOTARGET (2014)
Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells
G. Kenneth Gray et al.
ONCOTARGET (2014)
Hypophosphatemic Rickets: Revealing Novel Control Points for Phosphate Homeostasis
Kenneth E. White et al.
CURRENT OSTEOPOROSIS REPORTS (2014)
The CK1 family: contribution to cellular stress response and its role in carcinogenesis
Uwe Knippschild et al.
FRONTIERS IN ONCOLOGY (2014)
IGF binding proteins in cancer: mechanistic and clinical insights
Robert C. Baxter
NATURE REVIEWS CANCER (2014)
First Structure of Protein Kinase CK2 Catalytic Subunit with an Effective CK2β-Competitive Ligand
Jennifer Raaf et al.
ACS CHEMICAL BIOLOGY (2013)
Phosphorylation of cystic fibrosis transmembrane conductance regulator (CFTR) serine-511 by the combined action of tyrosine kinases and CK2: the implication of tyrosine-512 and phenylalanine-508
Luca Cesaro et al.
AMINO ACIDS (2013)
Pyrvinium pamoate does not activate protein kinase CK1, but promotes Akt/PKB down-regulation and GSK3 activation
Andrea Venerando et al.
BIOCHEMICAL JOURNAL (2013)
Discovery and characterization of synthetic 4′-hydroxyflavones-New CK2 inhibitors from flavone family
Andriy G. Golub et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Kinase CK2 Inhibition: An Update
G. Cozza et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Evaluation of CK2 inhibitor (E)-3-(2,3,4,5-tetrabromophenyl)acrylic acid (TBCA) in regulation of platelet function
Si-Yun Ryu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Exome sequencing reveals FAM20c mutations associated with fibroblast growth factor 23-related hypophosphatemia, dental anomalies, and ectopic calcification
Silje Hjorth Rafaelsen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity
Laura Quotti Tubi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Functional proteomics strategy for validation of protein kinase inhibitors reveals new targets for a TBB-derived inhibitor of protein kinase CK2
Laszlo Gyenis et al.
JOURNAL OF PROTEOMICS (2013)
Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells: Biochemical evidence and therapeutic perspectives
Christian Borgo et al.
MOLECULAR ONCOLOGY (2013)
CX-4945, a selective inhibitor of casein kinase-2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in chronic lymphocytic leukemia when combined with fludarabine and inhibitors of the B-cell receptor pathway
R. C. Prins et al.
LEUKEMIA (2013)
Crystal structure of the Golgi casein kinase
Junyu Xiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Secreted protein kinases
Vincent S. Tagliabracci et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
Coumestrol from the national cancer Institute's natural product library is a novel inhibitor of protein kinase CK2
Shu Liu et al.
BMC PHARMACOLOGY & TOXICOLOGY (2013)
2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε
Joachim Bischof et al.
AMINO ACIDS (2012)
Protein kinase CK2 is a regulator of angiogenesis in endometriotic lesions
Dilu Feng et al.
ANGIOGENESIS (2012)
Novel indeno[1,2-b]indoloquinones as inhibitors of the human protein kinase CK2 with antiproliferative activity towards a broad panel of cancer cell lines
Claas Hundsdoerfer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Inhibition of Protein Kinase CK2 by Flavonoids and Tyrphostins. A Structural Insight
Graziano Lolli et al.
BIOCHEMISTRY (2012)
2-Phenylamino-6-cyano-1H-benzimidazole-based isoform selective casein kinase 1 gamma (CK1γ) inhibitors
Zihao Hua et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Anti-androgen receptor activity of apoptotic CK2 inhibitor CX4945 in human prostate cancer LNCap cells
Byung Jun Ryu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells
Fabrice Pierre et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells
Joshua Bliesath et al.
CANCER LETTERS (2012)
Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A
Stefania Sarno et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Protein Kinase CK1α Regulates Erythrocyte Survival
Christine Zelenak et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2012)
The Human Adenovirus Type 5 E1B 55-Kilodalton Protein Is Phosphorylated by Protein Kinase CK2
Wilhelm Ching et al.
JOURNAL OF VIROLOGY (2012)
Protein kinase CK2 is implicated in early steps of the differentiation of pre-adipocytes into adipocytes
Nadine Wilhelm et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
A subnanomolar fluorescent probe for protein kinase CK2 interaction studies
Erki Enkvist et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2012)
The Raine Syndrome Protein FAM20C Is a Golgi Kinase That Phosphorylates Bio-Mineralization Proteins
Hiroyuki O. Ishikawa et al.
PLOS ONE (2012)
Effects of the CK2 Inhibitors CX-4945 and CX-5011 on Drug-Resistant Cells
Sofia Zanin et al.
PLOS ONE (2012)
Casein kinase 2 inhibition attenuates androgen receptor function and cell proliferation in prostate cancer cells
Kai Yao et al.
PROSTATE (2012)
Secreted Kinase Phosphorylates Extracellular Proteins That Regulate Biomineralization
Vincent S. Tagliabracci et al.
SCIENCE (2012)
Structure-Based Design of Potent and Selective CK1γ Inhibitors
Hongbing Huang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
The Lyn Kinase Activator MLR-1023 Is a Novel Insulin Receptor Potentiator that Elicits a Rapid-Onset and Durable Improvement in Glucose Homeostasis in Animal Models of Type 2 Diabetes
Alexander R. Ochman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer
Roberto Battistutta et al.
BIOCHEMISTRY (2011)
Novel potent pyrimido[4,5-c]quinoline inhibitors of protein kinase CK2: SAR and preliminary assessment of their analgesic and anti-viral properties
Fabrice Pierre et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
The SCPP Gene Family and the Complexity of Hard Tissues in Vertebrates
Kazuhiko Kawasaki
CELLS TISSUES ORGANS (2011)
Urolithin as a Converging Scaffold Linking Ellagic acid and Coumarin Analogues: Design of Potent Protein Kinase CK2 Inhibitors
Giorgio Cozza et al.
CHEMMEDCHEM (2011)
Casein Kinase 1-dependent Phosphorylation of Familial Advanced Sleep Phase Syndrome-associated Residues Controls PERIOD 2 Stability
Naval P. Shanware et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Structure-based discovery of novel flavonol inhibitors of human protein kinase CK2
Andriy G. Golub et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Protein kinase CK2: a catalyst for biology, medicine and structural biochemistry
Khalil Ahmed et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Protein kinase CK2 accumulation in oncophilic cells: causes and effects
Maria Ruzzene et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Down-regulation of CK2 activity results in a decrease in the level of cdc25C phosphatase in different prostate cancer cell lines
Carolin C. Schneider et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer
Fabrice Pierre et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Protein Kinases CK1 and CK2 as New Targets for Neurodegenerative Diseases
Daniel I. Perez et al.
MEDICINAL RESEARCH REVIEWS (2011)
IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ε and Wnt/β-catenin independent inhibition of mitotic spindle formation
J. K. Cheong et al.
ONCOGENE (2011)
The role of protein kinase CK2 in the regulation of the insulin production of pancreatic islets
Rui Meng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Cystic fibrosis transmembrane regulator fragments with the Phe508 deletion exert a dual allosteric control over the master kinase CK2
Mario A. Pagano et al.
BIOCHEMICAL JOURNAL (2010)
Addiction to protein kinase CK2: A common denominator of diverse cancer cells?
Maria Ruzzene et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Emergence of protein kinase CK2 as a key target in cancer therapy
Janeen H. Trembley et al.
BIOFACTORS (2010)
Antitumor Activity of Pyridocarbazole and Benzopyridoindole Derivatives that Inhibit Protein Kinase CK2
Renaud Prudent et al.
CANCER RESEARCH (2010)
CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy
Adam Siddiqui-Jain et al.
CANCER RESEARCH (2010)
Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4,5,6,7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro
Hanna Lawnicka et al.
CELL AND TISSUE RESEARCH (2010)
Isoform specific phosphorylation of p53 by protein kinase CK1
Andrea Venerando et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
CK2 Modulation of NF-κB, TP53, and the Malignant Phenotype in Head and Neck Cancer by Anti-CK2 Oligonucleotides In vitro or In vivo via Sub-50-nm Nanocapsules
Matthew S. Brown et al.
CLINICAL CANCER RESEARCH (2010)
Golgi apparatus casein kinase phosphorylates bioactive Ser-6 of bone morphogenetic protein 15 and growth and differentiation factor 9
Elena Tibaldi et al.
FEBS LETTERS (2010)
Motif Analysis of Phosphosites Discloses a Potential Prominent Role of the Golgi Casein Kinase (GCK) in the Generation of Human Plasma Phospho-Proteome
Mauro Salvi et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
Curtis A. Thorne et al.
NATURE CHEMICAL BIOLOGY (2010)
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Volker Brinkmann et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
CK1ε Is Required for Breast Cancers Dependent on β-Catenin Activity
So Young Kim et al.
PLOS ONE (2010)
Structure of human protein kinase CK2α2 with a potent indazole-derivative inhibitor
Tetsuko Nakaniwa et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2009)
Resorufin: a lead for a new protein kinase CK2 inhibitor
Iben Skjoth Sandholt et al.
ANTI-CANCER DRUGS (2009)
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2
Giorgio Cozza et al.
BIOCHEMICAL JOURNAL (2009)
Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis
Mauro Salvi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Tetraiodobenzimidazoles are potent inhibitors of protein kinase CK2
Alessandra Gianoncelli et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Structural insight into human CK2α in complex with the potent inhibitor ellagic acid
Yusuke Sekiguchi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library
Ming-Szu Hung et al.
BMC CANCER (2009)
Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies
Ana M. Solares et al.
BMC CANCER (2009)
Efficacy and mechanism of anti-tumor action of new potential CK2 inhibitors toward glioblastoma cells
Bozena Kaminska et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Autophosphorylation of Carboxy-Terminal Residues Inhibits the Activity of Protein Kinase CK1α
Mauricio Budini et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
3,4-Diaryl-isoxazoles and -imidazoles as Potent Dual Inhibitors of p38α Mitogen Activated Protein Kinase and Casein Kinase 1δ
Christian Peifer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Selective Inhibition of Casein Kinase 1ε Minimally Alters Circadian Clock Period
Kevin M. Walton et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Mutations in BMP4 cause eye, brain, and digit developmental anomalies:: Overlap between the BMP4 and hedgehog signaling pathways
Preeti Bakrania et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Modulation of protein kinase CK2 activity by fragments of CFTR encompassing F508 may reflect functional links with cystic fibrosis pathogenesis
Mario A. Pagano et al.
BIOCHEMISTRY (2008)
Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities
Zhe Nie et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Identification of novel protein kinase CK1 delta (CK1δ) inhibitors through structure-based virtual screening
Giorgio Cozza et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
The CK2α/CK2β interface of human protein kinase CK2 harbors a binding pocket for small molecules
Jennifer Raaf et al.
CHEMISTRY & BIOLOGY (2008)
Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2
Renaud Prudent et al.
CHEMISTRY & BIOLOGY (2008)
Phosphorylation of RhoB by CK1 impedes actin stress fiber organization and epidermal growth factor receptor stabilization
Vanessa Tillement et al.
EXPERIMENTAL CELL RESEARCH (2008)
Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo
C. Brockschmidt et al.
GUT (2008)
A central role for CK1 in catalyzing phosphorylation of the p53 transactivation domain at serine 20 after HHV-6B viral infection
Nicola J. MacLaine et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Down-regulation of catalase and oxidative modification of protein kinase CK2 lead to the failure of apoptosis repressor with caspase recruitment domain to inhibit cardiomyocyte hypertrophy
Iram Murtaza et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1
Nassima Oumata et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: An integrate approach to elucidate the putative binding motif and explain structure-activity relationships
Adriana Chilin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Protein kinase CK2, an important regulator of the inflammatory response?
Nishi N. Singh et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Specificity and regulation of casein kinase-mediated phosphorylation of α-synuclein
Elisa A. Waxman et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
SIX2 and BMP4 mutations associate with anomalous kidney development
Stefanie Weber et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Expanding the chemical diversity of CK2 inhibitors
Renaud Prudent et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis
Giovanni Di Maira et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo
Silvio E. Perea et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Identification of chemical inhibitors of protein-kinase CK2 subunit interaction
Beatrice Laudet et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases
K. Bettayeb et al.
ONCOGENE (2008)
Systemic administration of a peptide that impairs the Protein Kinase (CK2) phosphorylation reduces solid tumor growth in mice
Yasser Perera et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer
Akeila Bellahcene et al.
NATURE REVIEWS CANCER (2008)
Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction
Beatrice Laudet et al.
BIOCHEMICAL JOURNAL (2007)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
Prevalence of chronic kidney disease in the United States
Josef Coresh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Mutations in FAM20C are associated with lethal osteosclerotic bone dysplasia (Raine syndrome), highlighting a crucial molecule in bone development
M. A. Simpson et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT
Christina Westmose Yde et al.
CANCER LETTERS (2007)
Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis
Diane P. Hanger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2
Zhe Nie et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors
Mario A. Pagano et al.
CHEMBIOCHEM (2007)
CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: Protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system
Robert C. Axtell et al.
JOURNAL OF IMMUNOLOGY (2006)
Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2
Andriy G. Golub et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
The linoleic acid derivative DCP-LA selectively activates PKC-ε, possibly binding to the phosphatidylserine binding site
Takeshi Kanno et al.
JOURNAL OF LIPID RESEARCH (2006)
Identification of ellagic acid as potent inhibitor of protein kinase CK2: A successful example of a virtual screening application
G Cozza et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Casein kinase 1γ couples Wnt receptor activation to cytoplasmic signal transduction
G Davidson et al.
NATURE (2005)
The casein kinase I family:: participation in multiple cellular processes in eukaryotes
U Knippschild et al.
CELLULAR SIGNALLING (2005)
2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2
MA Pagano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Protein kinase CK1δ phosphorylates key sites in the acidic domain of murine double-minute clone 2 protein (MDM2) that regulate p53 turnover
M Winter et al.
BIOCHEMISTRY (2004)
Antitumor activity of pyrvinium pamoate, 6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H- pyrrol-3-yl)ethenyl]-1-methyl-quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation
H Esumi et al.
CANCER SCIENCE (2004)
Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization
AV Ljubimov et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a
G Rena et al.
EMBO REPORTS (2004)
Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer
A Lacy et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study
F Meggio et al.
BIOCHEMISTRY (2004)
Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2)
SE Perea et al.
CANCER RESEARCH (2004)
Modulation of mitogen-activated protein kinases by 6-nitro-7-hydroxycoumarin mediates apoptosis in renal carcinoma cells
G Finn et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA)
S Sarno et al.
BIOCHEMICAL JOURNAL (2003)
Phosphorylation of the potyvirus capsid protein by protein kinase CK2 and its relevance for virus infection
KI Ivanov et al.
PLANT CELL (2003)
Downregulation of Cap43 gene by !von Hippel-Lindau tumor suppressor protein in human renal cancer cells
K Masuda et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
One-thousand-and-one substrates of protein kinase CK2?
F Meggio et al.
FASEB JOURNAL (2003)
Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells
M Ruzzene et al.
BIOCHEMICAL JOURNAL (2002)
Toward the rational design of protein kinase casein kinase-2 inhibitors
S Sarno et al.
PHARMACOLOGY & THERAPEUTICS (2002)
Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme
K Niefind et al.
EMBO JOURNAL (2001)
HIV-1 Rev transactivator: A beta-subunit directed substrate and effector of protein kinase CK2
F Meggio et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2001)
IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects
L Behrend et al.
ONCOGENE (2000)
Crystal structure of a conformation-selective casein kinase-1 inhibitor
N Mashhoon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Casein kinase 1 delta mRNA is upregulated in Alzheimer disease brain
K Yasojima et al.
BRAIN RESEARCH (2000)
Share Paper
